Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Ertl

Showing results (91-100 of 402) with videos related to

Pageof 41
Sort By:
Journal of the American College of Cardiology|November 11, 2003
Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarctionDaniela Fraccarollo, Paolo Galuppo, Steven Hildemann, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 7, 2006
Soluble guanylyl cyclase activation with HMR1766 attenuates platelet activation in diabetic ratsAndreas Schäfer, Ulrike Flierl, Anna Kobsar, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 12, 2018
Symptom patterns and clinical outcomes in women versus men with systolic heart failure and depressionSven M Piepenburg, Hermann Faller, Stefan Störk, et al.
Journal of Psychosomatic Research|March 16, 2015
Depressive symptoms in heart failure: Independent prognostic factor or marker of functional status?Hermann Faller, Stefan Störk, Götz Gelbrich, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 15, 2018
Public funding for medical research in relation to the burden of disease caused by cardiovascular diseases and neoplasms in GermanyManuel Krone, Vera Dufner, Martin Wagner, et al.
International Journal of Cardiology|January 24, 2009
Impact of depression on quality of life assessment in heart failureHermann Faller, Thomas Steinbüchel, Stefan Störk, et al.
Deutsche Medizinische Wochenschrift (1946)|March 26, 2025
[Healthcare landscape in internal medicine in Germany: A trend analysis over 10 years for the German Society of Internal Medicine (DGIM)]Dirk Müller-Wieland, Elke Berger, Phillip Hengel, et al.
Cardiovascular Research|June 12, 2003
Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunctionAndreas Schäfer, Daniela Fraccarollo, Steven K Hildemann, et al.
Annals of Internal Medicine|July 2, 2008
Cardiac JAK2 mutation V617F in a patient with cardiomyopathy and myeloproliferative diseaseStefan Gattenlohner, Georg Ertl, Hermann Einsele, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|April 6, 2002
Ventricular remodeling after myocardial infarction and effects of ACE inhibition on hemodynamics and scar formation in SHRTomasz Zdrojewski, Peter Gaudron, Peter Whittaker, et al.
Pageof 41

Showing results (91-100 of 402) with videos related to

Sort By:
Pageof 41
Journal of the American College of Cardiology|November 11, 2003
Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarctionDaniela Fraccarollo, Paolo Galuppo, Steven Hildemann, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 7, 2006
Soluble guanylyl cyclase activation with HMR1766 attenuates platelet activation in diabetic ratsAndreas Schäfer, Ulrike Flierl, Anna Kobsar, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 12, 2018
Symptom patterns and clinical outcomes in women versus men with systolic heart failure and depressionSven M Piepenburg, Hermann Faller, Stefan Störk, et al.
Journal of Psychosomatic Research|March 16, 2015
Depressive symptoms in heart failure: Independent prognostic factor or marker of functional status?Hermann Faller, Stefan Störk, Götz Gelbrich, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 15, 2018
Public funding for medical research in relation to the burden of disease caused by cardiovascular diseases and neoplasms in GermanyManuel Krone, Vera Dufner, Martin Wagner, et al.
International Journal of Cardiology|January 24, 2009
Impact of depression on quality of life assessment in heart failureHermann Faller, Thomas Steinbüchel, Stefan Störk, et al.
Deutsche Medizinische Wochenschrift (1946)|March 26, 2025
[Healthcare landscape in internal medicine in Germany: A trend analysis over 10 years for the German Society of Internal Medicine (DGIM)]Dirk Müller-Wieland, Elke Berger, Phillip Hengel, et al.
Cardiovascular Research|June 12, 2003
Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunctionAndreas Schäfer, Daniela Fraccarollo, Steven K Hildemann, et al.
Annals of Internal Medicine|July 2, 2008
Cardiac JAK2 mutation V617F in a patient with cardiomyopathy and myeloproliferative diseaseStefan Gattenlohner, Georg Ertl, Hermann Einsele, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|April 6, 2002
Ventricular remodeling after myocardial infarction and effects of ACE inhibition on hemodynamics and scar formation in SHRTomasz Zdrojewski, Peter Gaudron, Peter Whittaker, et al.
Pageof 41